GDSCTools for mining pharmacogenomic interactions in cancer

61Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Motivation Large pharmacogenomic screenings integrate heterogeneous cancer genomic datasets as well as anti-cancer drug responses on thousand human cancer cell lines. Mining this data to identify new therapies for cancer sub-populations would benefit from common data structures, modular computational biology tools and user-friendly interfaces. Results We have developed GDSCTools: A software aimed at the identification of clinically relevant genomic markers of drug response. The Genomics of Drug Sensitivity in Cancer (GDSC) database (www.cancerRxgene.org) integrates heterogeneous cancer genomic datasets as well as anti-cancer drug responses on a thousand cancer cell lines. Including statistical tools (analysis of variance) and predictive methods (Elastic Net), as well as common data structures, GDSCTools allows users to reproduce published results from GDSC and to implement new analytical methods. In addition, non-GDSC data resources can also be analysed since drug responses and genomic features can be encoded as CSV files. Contact thomas.cokelaer@pasteur.fr or saezrodriguez.rwth-Aachen.de or mg12@sanger.ac.UK Supplementary informationSupplementary dataare available at Bioinformatics online.

Cite

CITATION STYLE

APA

Cokelaer, T., Chen, E., Iorio, F., Menden, M. P., Lightfoot, H., Saez-Rodriguez, J., & Garnett, M. J. (2018). GDSCTools for mining pharmacogenomic interactions in cancer. Bioinformatics, 34(7), 1226–1228. https://doi.org/10.1093/bioinformatics/btx744

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free